Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome

PURPOSE: This study aimed to assess the efficacy of high‐dose i.v. immunoglobulin (HIVIg) therapy in pregnant women with antiphospholipid syndrome (APS) secondary to systemic lupus erythematosus with a history of pregnancy failure, despite receiving low‐dose aspirin plus unfractionated heparin thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Maesawa, Yoko, Deguchi, Masashi, Tanimura, Kenji, Morizane, Mayumi, Ebina, Yasuhiko, Yamada, Hideto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902467/
https://www.ncbi.nlm.nih.gov/pubmed/29692672
http://dx.doi.org/10.1002/rmb2.12080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902467/
https://www.ncbi.nlm.nih.gov/pubmed/29692672
http://dx.doi.org/10.1002/rmb2.12080

Ejemplares similares